ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface - PubMed (original) (raw)
ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface
Mitchell B Berger et al. FEBS Lett. 2004.
Free article
Abstract
To understand signaling by the neuregulin (NRG) receptor ErbB3/HER3, it is important to know whether ErbB3 forms homodimers upon ligand binding. Previous biophysical studies suggest that the ErbB3 extracellular region remains monomeric when bound to NRG. We used a chimeric receptor approach to address this question in living cells, fusing the extracellular region of ErbB3 to the kinase-active intracellular domain of ErbB1. The ErbB3/ErbB1 chimera responded to NRG only if ErbB2 was co-expressed in the same cells, whereas an ErbB4/ErbB1 chimera responded without ErbB2. We, therefore, suggest that ErbB3 is an obligate heterodimerization partner because of its inability to homodimerize.
Similar articles
- Expression, localization, and regulation of the neuregulin receptor ErbB3 in mouse heart.
Campreciós G, Lorita J, Pardina E, Peinado-Onsurbe J, Soley M, Ramírez I. Campreciós G, et al. J Cell Physiol. 2011 Feb;226(2):450-5. doi: 10.1002/jcp.22354. J Cell Physiol. 2011. PMID: 20672328 - Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
Li Z, Mei Y, Liu X, Zhou M. Li Z, et al. Cell Signal. 2007 Mar;19(3):466-71. doi: 10.1016/j.cellsig.2006.07.020. Epub 2006 Sep 15. Cell Signal. 2007. PMID: 16978839 - Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
Thompson M, Lauderdale S, Webster MJ, Chong VZ, McClintock B, Saunders R, Weickert CS. Thompson M, et al. Brain Res. 2007 Mar 30;1139:95-109. doi: 10.1016/j.brainres.2006.11.047. Epub 2007 Feb 5. Brain Res. 2007. PMID: 17280647 - The neuregulin-I/ErbB signaling system in development and disease.
Britsch S. Britsch S. Adv Anat Embryol Cell Biol. 2007;190:1-65. Adv Anat Embryol Cell Biol. 2007. PMID: 17432114 Review. - The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R Jr. Roskoski R Jr. Pharmacol Res. 2014 Jan;79:34-74. doi: 10.1016/j.phrs.2013.11.002. Epub 2013 Nov 20. Pharmacol Res. 2014. PMID: 24269963 Review.
Cited by
- HER4 is a high-affinity dimerization partner for all EGFR/HER/ErbB family proteins.
Singh PK, Kim S, Smith AW. Singh PK, et al. Protein Sci. 2024 Oct;33(10):e5171. doi: 10.1002/pro.5171. Protein Sci. 2024. PMID: 39276020 - HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of Cancer.
Majumder A. Majumder A. Cells. 2023 Oct 25;12(21):2517. doi: 10.3390/cells12212517. Cells. 2023. PMID: 37947595 Free PMC article. Review. - Peptide G-Protein-Coupled Receptors and ErbB Receptor Tyrosine Kinases in Cancer.
Moody TW, Ramos-Alvarez I, Jensen RT. Moody TW, et al. Biology (Basel). 2023 Jul 4;12(7):957. doi: 10.3390/biology12070957. Biology (Basel). 2023. PMID: 37508387 Free PMC article. Review. - ERBB Receptors and Their Ligands in the Developing Mammary Glands of Different Species: Fifteen Characters in Search of an Author.
Morato A, Accornero P, Hovey RC. Morato A, et al. J Mammary Gland Biol Neoplasia. 2023 May 23;28(1):10. doi: 10.1007/s10911-023-09538-w. J Mammary Gland Biol Neoplasia. 2023. PMID: 37219601 Free PMC article. Review. - NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer.
Purazo ML, Ice RJ, Shimpi R, Hoenerhoff M, Pugacheva EN. Purazo ML, et al. Cancers (Basel). 2023 Feb 9;15(4):1119. doi: 10.3390/cancers15041119. Cancers (Basel). 2023. PMID: 36831460 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous